Lohmann Therapie-Systeme
Yu Jiang is a seasoned professional in the pharmaceutical industry with extensive experience in analytical method development and validation. Currently serving as a Sr Scientist at LTS Lohmann Therapie-Systeme AG since February 2020, Yu Jiang has demonstrated expertise in analytical method evaluation, optimization, and compendial method verification. Prior roles include Sr Analytical Scientist at Amerigen Pharmaceuticals, where responsibilities involved overseeing method development and providing technical support, and Research Scientist at PuraCap Pharmaceutical, focusing on the validation and transfer of analytical methods. Earlier positions at Primera Analytical Solutions Corp. and Tris Pharma involved method evaluation and reverse engineering to support ANDA projects. Yu Jiang holds a Bachelor of Applied Science in Pharmacy from Shenyang Pharmaceutical University, completed in 2007.
This person is not in any offices
Lohmann Therapie-Systeme
LTS is the market leader in transdermal therapeutic systems and oral thin films. We develop and manufacture innovative drug delivery systems that offer the patient reliable therapeutic efficacy with the highest level of convenience and comfort – the benefits of which have already proven themselves on the global markets.